Literature DB >> 21274751

Prognostic markers and staging systems for patients with colorectal liver metastases.

James J Mezhir1, Michael I D'Angelica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21274751     DOI： 10.1007/s11605-011-1424-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  10 in total

1.  T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.

Authors:  Steven C Katz; Venu Pillarisetty; Zubin M Bamboat; Jinru Shia; Cyrus Hedvat; Mithat Gonen; William Jarnagin; Yuman Fong; Leslie Blumgart; Michael D'Angelica; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2009-07-01       Impact factor: 5.344

2.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

3.  Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.

Authors:  S Iwatsuki; I Dvorchik; J R Madariaga; J W Marsh; F Dodson; A C Bonham; D A Geller; T J Gayowski; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  1999-09       Impact factor: 6.113

4.  Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.

Authors:  Srinevas K Reddy; Michael W Kattan; Changhong Yu; Eugene P Ceppa; Sebastian G de la Fuente; Yuman Fong; Bryan M Clary; Rebekah R White
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

5.  Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients.

Authors:  Myrddin Rees; Paris P Tekkis; Fenella K S Welsh; Thomas O'Rourke; Timothy G John
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

6.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

7.  A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.

Authors:  Michael W Kattan; Mithat Gönen; William R Jarnagin; Ronald DeMatteo; Michael D'Angelica; Martin Weiser; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg       Date:  2008-02       Impact factor: 12.969

8.  Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.

Authors:  David J Gallagher; Junting Zheng; Marinela Capanu; Dana Haviland; Philip Paty; Robert P Dematteo; Michael D'Angelica; Yuman Fong; William R Jarnagin; Peter J Allen; Nancy Kemeny
Journal:  Ann Surg Oncol       Date:  2009-02-18       Impact factor: 5.344

9.  Hepatic resection for colorectal metastases: value for risk scoring systems?

Authors:  Shaheen Zakaria; John H Donohue; Florencia G Que; Michael B Farnell; Cathy D Schleck; Duane M Ilstrup; David M Nagorney
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

10.  K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Authors:  Christos S Karapetis; Shirin Khambata-Ford; Derek J Jonker; Chris J O'Callaghan; Dongsheng Tu; Niall C Tebbutt; R John Simes; Haji Chalchal; Jeremy D Shapiro; Sonia Robitaille; Timothy J Price; Lois Shepherd; Heather-Jane Au; Christiane Langer; Malcolm J Moore; John R Zalcberg
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.